The Centre for the Commercialization of Antibodies and Biologics (CCAB) provides expertise in product and business development to rapidly translate academic discoveries toward achieving a sustainable impact within the healthcare system and the broader scientific research community.
Services & Solutions
CCAB experts combine in-house capabilities in the development of therapeutics, diagnostics and reagents, with the support of start-up companies in these areas.
News & Views
See how CCAB is developing robust pipelines in antibodies and biologics.